We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+18.1%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.52B
AUM Growth
+$95.3M
Cap. Flow
-$53M
Cap. Flow %
-3.48%
Top 10 Hldgs %
46.4%
Holding
811
New
169
Increased
201
Reduced
172
Closed
223

Top Buys

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$66.9M
2
SAGE
Sage Therapeutics
SAGE
+$26.6M
3
IMO icon
Imperial Oil
IMO
+$24.9M
4
COIN icon
Coinbase
COIN
+$22.5M
5
ANSCU
Agriculture & Natural Solutions Acquisition Corp Unit
ANSCU
+$21.6M

Top Sells

Rank Stock Value
1
MSOS icon
AdvisorShares Pure US Cannabis ETF
MSOS
+$48.7M
2
AAC
Ares Acquisition Corporation
AAC
+$36.4M
3
PTGX icon
Protagonist Therapeutics
PTGX
+$27.6M
4
HCVIU
Hennessy Capital Investment Corp. VI Unit
HCVIU
+$17.4M
5
NETD
Nabors Energy Transition Corp II
NETD
+$16.9M

Sector Composition

Rank Sector Weight
1 Healthcare 30.8%
2 Financials 24.54%
3 Technology 21.73%
4 Communication Services 4.41%
5 Energy 3.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRCA
776
DELISTED
Twin Ridge Capital Acquisition Corp.
TRCA
– –
-154,735
Closed -$1.58M
TMPOW
777
DELISTED
Tempo Automation Holdings, Inc. Warrant
TMPOW
– –
-90,994
Closed -$818
FRBN
778
DELISTED
Forbion European Acquisition Corp. Class A Ordinary Shares
FRBN
– –
-739,320
Closed -$8.1M
BOAC
779
DELISTED
Bluescape Opportunities Acquisition Corp.
BOAC
– –
-58,941
Closed -$591K
BODY.WS
780
DELISTED
The Beachbody Company, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
BODY.WS
– –
-391,935
Closed -$7.45K
SKIL.WS
781
DELISTED
Skillsoft Corp. Warrants, each whole warrant is exercisable for 1/20th of a share of Class A Common Stock at an exercise price of $230.00
SKIL.WS
– –
-1,348,644
Closed -$15K
NFNT.WS
782
DELISTED
Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFNT.WS
– –
-196,772
Closed -$7.87K
NFNT
783
DELISTED
Infinite Acquisition Corp.
NFNT
– –
-464,815
Closed -$5M
VHAQ.WS
784
DELISTED
Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share
VHAQ.WS
– –
-113,700
Closed -$2.96K
CXAC.WS
785
DELISTED
C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
CXAC.WS
– –
-79,888
Closed -$2.96K
ACAQ.WS
786
DELISTED
Athena Consumer Acquisition Corp. Redeemable warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock for $11.50 per share
ACAQ.WS
– –
-55,500
Closed -$20K
ACAQ
787
DELISTED
Athena Consumer Acquisition Corp.
ACAQ
– –
-10,000
Closed -$74.6K
HPLT
788
DELISTED
Home Plate Acquisition Corporation Class A Common Stock
HPLT
– –
-74,760
Closed -$817K
HPLTW
789
DELISTED
Home Plate Acquisition Corporation Warrant
HPLTW
– –
-465,304
Closed -$16K
CCV
790
DELISTED
Churchill Capital Corp V
CCV
– –
-888,885
Closed -$9.24M
BTWN
791
DELISTED
Bridgetown Holdings Limited Class A Ordinary Shares
BTWN
– –
-58,161
Closed -$603K
SSU.WS
792
DELISTED
SIGNA Sports United N.V. Public Warrants, each whole warrant to purchase one Ordinary Shares at an exercise price of $11.50
SSU.WS
– –
-50,099
Closed -$500
SAMAW
793
DELISTED
Schultze Special Purpose Acquisition Corp. II Warrant
SAMAW
– –
-108,908
Closed -$544
JUN
794
DELISTED
Juniper II Corp.
JUN
– –
-331,347
Closed -$3.51M
BIOS
795
DELISTED
BioPlus Acquisition Corp. Class A Ordinary Shares
BIOS
– –
-679,393
Closed -$7.36M
BIOSW
796
DELISTED
BioPlus Acquisition Corp. Warrants
BIOSW
– –
-522,096
Closed -$29.2K
FZT.WS
797
DELISTED
FAST Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
FZT.WS
– –
-19,800
Closed -$9.9K
LFAC
798
DELISTED
LF Capital Acquisition Corp. II Class A Common Stock
LFAC
– –
-74,996
Closed -$814K
LFACW
799
DELISTED
LF Capital Acquisition Corp. II Warrants
LFACW
– –
-74,593
Closed -$275
MPRAW
800
DELISTED
Mercato Partners Acquisition Corporation Warrant
MPRAW
– –
-78,419
Closed -$16.5K
29 30 31
32
33

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q4 2023 Portfolio in Review

As of Q4 2023, Cowen and Company held 811 positions worth $1.52B, up 6.7% from $1.43B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Cowen and Company withdrew a net $53M in Q4 2023, closing 223 positions and reducing 172 holdings. Its most notable exit was AdvisorShares Pure US Cannabis ETF, an estimated $48.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 22% a quarter earlier, followed by Financials and Technology.

Against the trend, Cowen and Company opened a new position in Sage Therapeutics worth $29M.

  • Cowen and Company's largest Q4 2023 buy was Sage Therapeutics: 1,339,971 shares worth $29M.
  • Cowen and Company added most to PTC Therapeutics in Q4 2023, an estimated $66.9M increase.
  • Cowen and Company's biggest Q4 2023 reduction was Nabors Energy Transition Corp II, cutting an estimated $16.9M.
  • Cowen and Company fully exited AdvisorShares Pure US Cannabis ETF in Q4 2023, selling an estimated $48.7M.
  • Cowen and Company's ten largest holdings make up 46% of its $1.52B portfolio in Q4 2023.
  • Cowen and Company opened 169 new positions and closed 223 in Q4 2023.
  • Cowen and Company's portfolio value rose 6.7% quarter-over-quarter to $1.52B.

Based on Cowen and Company's 13F filing for Q4 2023, filed 8 Feb 2024.